REGENXBIO (RGNX) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free RGNX Stock Alerts $15.90 +0.26 (+1.66%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Raymond James & Associatesmarketbeat.com - April 23 at 4:04 AMMirae Asset Global Investments Co. Ltd. Reduces Holdings in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - April 21 at 4:35 AMKenneth T. Mills Sells 15,000 Shares of REGENXBIO Inc. (NASDAQ:RGNX) Stockinsidertrades.com - April 19 at 5:32 AMREGENXBIO (NASDAQ:RGNX) Stock Price Down 3.1% Following Insider Sellingamericanbankingnews.com - April 19 at 1:22 AMREGENXBIO (NASDAQ:RGNX) Shares Down 3.1% Following Insider Sellingmarketbeat.com - April 18 at 11:42 AMInsider Selling: REGENXBIO Inc. (NASDAQ:RGNX) CEO Sells 15,000 Shares of Stockmarketbeat.com - April 17 at 6:39 PMREGENXBIO Inc.'s (NASDAQ:RGNX) recent 7.9% pullback adds to one-year year losses, institutional owners may take drastic measuresfinance.yahoo.com - April 17 at 10:55 AMREGENXBIO's (RGNX) Buy Rating Reaffirmed at Stifel Nicolausamericanbankingnews.com - April 14 at 3:26 AMWhere Regenxbio Stands With Analystsmarkets.businessinsider.com - April 12 at 1:03 PMREGENXBIO (NASDAQ:RGNX) Earns "Buy" Rating from Stifel Nicolausmarketbeat.com - April 12 at 12:15 PMREGENXBIO Inc. (NASDAQ:RGNX) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - April 6 at 2:58 AMAssenagon Asset Management S.A. Invests $1.92 Million in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - April 5 at 4:29 AMRegenxbio Stock (NASDAQ:RGNX), Quotes and News Summarybenzinga.com - March 31 at 10:27 PMREGENXBIO (NASDAQ:RGNX) Stock Price Down 2%marketbeat.com - March 28 at 4:33 PMREGENXBIO Sees Positive Results For Macular Degeneration Therapyfinance.yahoo.com - March 28 at 1:40 PMREGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMDprnewswire.com - March 28 at 7:05 AMREGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Daysfinance.yahoo.com - March 27 at 5:33 PMREGENXBIO (NASDAQ:RGNX) Raised to Hold at StockNews.commarketbeat.com - March 21 at 2:20 AMREGENXBIO Inc. (NASDAQ:RGNX) CEO Sells $327,900.00 in Stockinsidertrades.com - March 19 at 5:00 AMRegenxbio Inc (RGNX) President and CEO Kenneth Mills Sells 15,000 Sharesfinance.yahoo.com - March 18 at 9:18 PMREGENXBIO Inc. (NASDAQ:RGNX) Insider Steve Pakola Sells 12,878 Sharesinsidertrades.com - March 17 at 7:41 AMChardan Capital Comments on REGENXBIO Inc.'s FY2024 Earnings (NASDAQ:RGNX)marketbeat.com - March 14 at 6:57 AMRockville biotech raises $140M following layoffs, program cutsbizjournals.com - March 12 at 8:13 PMREGENXBIO (NASDAQ:RGNX) Upgraded at StockNews.commarketbeat.com - March 11 at 11:15 PMRegenxbio: DMD Program Lends Additional Credibility To NAV Technology Platformseekingalpha.com - March 11 at 2:02 PMRegenxbio initiated with bullish view at H.C. Wainwright, here's whyrealmoney.thestreet.com - March 11 at 2:02 PMHC Wainwright Initiates Coverage on REGENXBIO (NASDAQ:RGNX)marketbeat.com - March 11 at 10:23 AMREGENXBIO to Participate in Upcoming Investor Conferencesprnewswire.com - March 11 at 7:05 AMLeerink Partnrs Equities Analysts Boost Earnings Estimates for REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - March 11 at 1:45 AMRBC Capital gets more bullish on Regenxbio, upgrades sharesrealmoney.thestreet.com - March 8 at 2:22 PMRBC Capital upgrades Regenxbio to Outperform, sees positive risk-rewardrealmoney.thestreet.com - March 8 at 2:22 PMRegenxbio raised to Buy at RBC on pivot to Duchennemsn.com - March 8 at 2:22 PMThis Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIOmarkets.businessinsider.com - March 8 at 2:22 PMRegenxbio Inc (RGNX) Chief Medical Officer Steve Pakola Sells 12,878 Sharesfinance.yahoo.com - March 8 at 8:38 AMREGENXBIO (NASDAQ:RGNX) Raised to Outperform at Royal Bank of Canadamarketbeat.com - March 8 at 8:21 AMREGENXBIO Inc. (NASDAQ:RGNX) Expected to Earn Q1 2024 Earnings of ($1.24) Per Sharemarketbeat.com - March 8 at 6:19 AMBearish: Analysts Just Cut Their REGENXBIO Inc. (NASDAQ:RGNX) Revenue and EPS estimatesfinance.yahoo.com - March 7 at 3:33 PMREGENXBIO's (RGNX) Buy Rating Reaffirmed at Chardan Capitalmarketbeat.com - March 7 at 10:33 AMAnalysts Are Bullish on These Healthcare Stocks: RegenXBio (RGNX), Biomea Fusion (BMEA)markets.businessinsider.com - March 7 at 10:32 AMREGENXBIO (NASDAQ:RGNX) PT Raised to $55.00marketbeat.com - March 7 at 8:20 AMLeerink Partnrs Comments on REGENXBIO Inc.'s FY2028 Earnings (NASDAQ:RGNX)marketbeat.com - March 7 at 7:53 AMREGENXBIO (NASDAQ:RGNX) Raised to "Outperform" at Leerink Partnrsmarketbeat.com - March 7 at 6:35 AMREGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrantsprnewswire.com - March 6 at 11:20 PMLatest News for Regenxbio Stock (NASDAQ:RGNX)benzinga.com - March 6 at 6:35 PMLeerink gets more bullish on Regenxbio, upgrades sharesrealmoney.thestreet.com - March 6 at 6:35 PMLeerink more bullish on Regenxbio, upgrades to Outperformrealmoney.thestreet.com - March 6 at 6:35 PMRegenXBio’s RGX-202 Hold Rating: Balancing Promising DMD Trial Outcomes with Competitive Market Challengesmarkets.businessinsider.com - March 6 at 6:35 PMREGENXBIO's Muscle Wasting Disorder Drug Shows Strength, Improved Motor Function, Stock Soarsmsn.com - March 6 at 6:35 PMRegenxbio stock jumps 13% on positive data for DMD drugmsn.com - March 6 at 6:35 PMBeyond The Numbers: 4 Analysts Discuss Regenxbio Stockmarkets.businessinsider.com - March 6 at 6:35 PM Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address The system that called 2023’s top 7 stocks is at it again… (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! RGNX Media Mentions By Week RGNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼0.660.46▲Average Medical News Sentiment RGNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼83▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMTX News RLAY News CRGX News CABA News BCRX News CGEM News KYTX News ADAP News HLVX News PRME News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
